New York Life Investment Management »

Entrada Therapeutics shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $367k 26k 14.17

More positions owned by New York Life Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Amazon (AMZN)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Indexiq Etf Tr Candriam Us Mid (IQSM)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Indexiq Etf Tr Candriam Interna (IQSI)
Meta Platforms Cl A (META)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Alphabet Cap Stk Cl A (GOOGL)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
T. Rowe Price Associates
BlackRock
Redmile Group
Vanguard Group
Wellington Management Company
StepStone
TCG Crossover Management
Geode Capital Management
State Street Corporation
American Century Companies
Northern Trust
FMR

View all funds holding Entrada Therapeutics